Advertisement
Canada markets open in 43 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7325
    +0.0002 (+0.02%)
     
  • CRUDE OIL

    84.22
    +0.65 (+0.78%)
     
  • Bitcoin CAD

    87,873.22
    +873.81 (+1.00%)
     
  • CMC Crypto 200

    1,389.72
    -6.82 (-0.49%)
     
  • GOLD FUTURES

    2,360.00
    +17.50 (+0.75%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.6630
    -0.0430 (-0.91%)
     
  • NASDAQ futures

    17,745.00
    +177.50 (+1.01%)
     
  • VOLATILITY

    16.06
    +0.69 (+4.49%)
     
  • FTSE

    8,127.11
    +48.25 (+0.60%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6831
    +0.0010 (+0.15%)
     

Market is Bouncing and This Company is Set to Do the Same

HENDERSON, NV / ACCESSWIRE / October 26, 2018 / After pouring over several companies, we've found a few that look set for a major bounce in conjunction with the market. One company we like a lot that is prime for a rebound is BioRestorative Therapies, Inc. (BRTX) a life sciences company focused on stem cell-based therapies. BRTX has been receiving positive findings on their lead cell therapy candidate BRTX-100.

The reason we think it may be time to act now is based on the stocks recent trading activity. Investors first started showing interest in the stock back in July, since the increase in activity, the stock has made some incredible moves making investors and traders alike. After reaching nearly $3 a share toward the end of September the stock began retracing to support.

BRTX looks like it has found that support and is on the brink of its next run. Do not miss this potential monster.

Companies to put on your radar include: BioRestorative Therapies, Inc. (BRTX), MedMen Enterprises, Inc. (MMNFF), OrganiGram Holdings, Inc. (OGRMF), Aurora Cannabis, Inc. (NYSE: ACB; OTC PINK: ACBFF), and Aphria, Inc. (APHQF).

ADVERTISEMENT

BioRestorative Therapies, Inc. (BRTX)

Market Cap: $11.24M Share Price: $1.25

BioRestorative Therapies, Inc. (BRTX), a life sciences company focused on stem cell-based therapies, announced the appointment of Lance Alstodt as Executive Vice President and Chief Strategy Officer. In this capacity, Mr. Alstodt will be responsible for developing and refining the Company's overall strategy and implementing investment decisions. Mr. Alstodt brings over 25 years of experience in operations, strategy and mergers & acquisitions.

MedMen Enterprises, Inc. (MMNFF)

Market Cap: $355.62M Share Price: $5.02

MedMen Enterprises, Inc. (MMNFF) announced that it has signed a definitive agreement to acquire Viktorya's Medical Supplies LLC d/b/a Buddy's Cannabis; a microbusiness license entitling the Company to retail, distribute, cultivate and manufacture cannabis onsite in San Jose, California. This will be MedMen's second retail store in Northern California.

OrganiGram Holdings, Inc. (OGRMF)

Market Cap: $564.25M Share Price: $4.33

Organigram Holdings Inc., a leading licensed producer of medical marijuana, recently announced its medicinal cannabis plants and growing process has been certified organic with Ecocert Canada.

Aurora Cannabis, Inc. (ACB)

Market Cap: $9.56B Share Price: $9.96

The company has begun trading on the NYSE, but the company's stock has been getting beat up. The company has reported that it has been granted the ability to ship cannabis to Poland, which is very favorable for the company and its shareholders. Watch for ACB to make a bounce in the company weeks.

Aphria, Inc. (APHQF)

Market Cap: $3.11B Share Price: $12.39

Aphria Inc. (APHQF) announced closing the acquisition of LATAM Holdings Inc. from Scythian Biosciences (SCCYF). The Transaction was funded by the assumption of US$1 million of existing LATAM Holdings debt with the remaining consideration funded by the issuance of 15,678,310 common shares of Aphria. The closing was pursuant to the terms of the definitive share purchase agreement previously announced by the Company on July 17, 2018.

Important Disclaimer, Please Read:

The securities, investments, and industries referenced and impacted in the attached content, are risky investments, that can result in significant or entire loss. This article is not advice in making any speculative investment decision.

The attached content may include predictions, estimates or other information that might be considered forward-looking. While such forward-looking statements represent best judgment on what the future holds, at the time of first publishing, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on any forward-looking statements, that may be found in the attached content, as they only reflect as of the date of first publishing. Please keep in mind that authors, producers, disseminators are not obligated to revise or publicly release the results of any revision to any forward-looking statement, that may be found in the attached content, in light of new information or future events.

Regal Consulting LLC is hired by certain companies to increase awareness and disseminate material public information regarding the paying company. DCTH has paid, and continues to pay Regal to disseminate truthful and potentially material information regarding DCTH.

Regal Consulting LLC is not registered with FINRA or any other financial or securities regulatory authority, and does not provide investment advice. The attached content is not investment advice. Regal Consulting LLC is not a broker dealer.

Before making investment decisions, everyone, including viewers of this content, should seek advice and perform deep and thorough research.

Regal Consulting, LLC. may buy or sell additional shares of any company named, referenced, or impacted by information in the attached content, on the open market at any time, including before, during or after the publishing of the content. The amount of stock Regal may own in DCTH can be found updated here: http://www.regalconsultingllc.com/disclaimer/.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and twenty two thousand dollars total by Regal Consulting. LLC, for news commentary articles for DCTH. DCTH and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. We may buy or sell additional shares of DCTH in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

For Full Legal Disclaimer Click Here.

Regal Consulting. LLC, For Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators

Contact Person: Media Manager

Email: info@microcapspecualtors.com

Phone: 1-702-720-6310

Country: United States

Website: http://microcapspeculators.com/

SOURCE: ACR Communication, LLC